| Ident. | Authors (with country if any) | Title |
|---|
| 000773 (2012) |
Francesca Gobbini [Royaume-Uni] ; Shirley Owusu-Ofori [Royaume-Uni] ; Anne-Geneviève Marcelin [Royaume-Uni] ; Daniel Candotti [Royaume-Uni] ; Jean-Pierre Allain [Royaume-Uni] | Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa |
| 000893 (2011) |
Barbara Foglieni [Royaume-Uni] ; Daniel Candotti [Royaume-Uni] ; Irene Guarnori [Royaume-Uni] ; Livia Raffaele [Royaume-Uni] ; Alessandra Berzuini [Royaume-Uni] ; Marta Spreafico [Royaume-Uni] ; Anna Orani [Royaume-Uni] ; Roberto Rossotti [Royaume-Uni] ; Davide Rossi [Royaume-Uni] ; Jean-Pierre Allain [Royaume-Uni] ; Daniele Prati [Royaume-Uni] | A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays |
| 000954 (2010) |
Julie Fox [Royaume-Uni] ; Helen Dunn [Royaume-Uni] ; Siobhan O'Shea [Royaume-Uni] | Low rates of p24 antigen detection using a fourth-generation point of care HIV test |
| 000975 (2010) |
S. V. Basavaraju [États-Unis] ; J. Mwangi [Kenya] ; J. Nyamongo [Kenya] ; C. Zeh [Kenya] ; D. Kimani [Kenya] ; R. W. Shiraishi [États-Unis] ; R. Madoda [Kenya] ; J. A. Okonji [Kenya] ; W. Sugut [Kenya] ; S. Ongwae [Kenya] ; J. P. Pitman [États-Unis] ; L. H. Marum [États-Unis] | Reduced risk of transfusion‐transmitted HIV in Kenya through centrally co‐ordinated blood centres, stringent donor selection and effective p24 antigen‐HIV antibody screening |
| 000983 (2010) |
Mpho Magwalivha [Afrique du Sud] ; Marianne Wolfaardt [Afrique du Sud] ; Nicholas M. Kiulia [Kenya] ; Walda B. Van Zyl [Afrique du Sud] ; Jason M. Mwenda [Kenya] ; Maureen B. Taylor [Afrique du Sud] | High prevalence of species D human adenoviruses in fecal specimens from Urban Kenyan children with diarrhea |
| 000994 (2010) |
Souichi Nukuzuma ; Kazuo Nakamichi ; Masanori Kameoka ; Shigeki Sugiura ; Chiyoko Nukuzuma ; Isao Miyoshi ; Tsutomu Takegami [Japon] | Efficient propagation of progressive multifocal leukoencephalopathy‐type JC virus in COS‐7‐derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1 |
| 000995 (2010) |
M. Vermeulen [Afrique du Sud] ; R. Reddy [Afrique du Sud] | Current screening strategies for blood donor screening in developing countries |
| 000A71 (2009) |
Lara Isobel Compston [Royaume-Uni] ; Chengyao Li [République populaire de Chine] ; Francis Sarkodie [Ghana] ; Shirley Owusu-Ofori [Ghana] ; Ohene Opare-Sem [Ghana] ; Jean-Pierre Allain [Royaume-Uni] | Prevalence of persistent and latent viruses in untreated patients infected with HIV‐1 from Ghana, West Africa |
| 000A81 (2009) |
Kishor M. Kwara [États-Unis] ; Kishor M. Lartey [Ghana] ; Kishor M. Boamah [Ghana] ; Kishor M. Rezk [États-Unis] ; Kishor M. Oliver-Commey [Ghana] ; Kishor M. Kenu [Ghana] ; Kishor M. Kashuba [États-Unis] ; Kishor M. Court [États-Unis] | Interindividual Variability in Pharmacokinetics of Generic Nucleoside Reverse Transcriptase Inhibitors in TB/HIV‐Coinfected Ghanaian Patients: UGT2B7*1c Is Associated With Faster Zidovudine Clearance and Glucuronidation |
| 000A97 (2009) |
Marinus Van Hulst [Pays-Bas] ; Gijs A. A. Hubben [Pays-Bas] ; Kwamena W. C. Sagoe [Pays-Bas] ; Charupon Promwong [Pays-Bas] ; Parichart Permpikul [Pays-Bas] ; Ladda Fongsatitkul [Pays-Bas] ; Diarmuid M. Glynn [Pays-Bas] ; Cees T. Smit Sibinga [Pays-Bas] ; Maarten J. Postma [Pays-Bas] | BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands |
| 000B01 (2009) |
Souichi Nukuzuma ; Masanori Kameoka [Japon] ; Shigeki Sugiura ; Kazuo Nakamichi ; Chiyoko Nukuzuma ; Isao Miyoshi ; Tsutomu Takegami [Japon] | Archetype JC virus efficiently propagates in kidney‐derived cells stably expressing HIV‐1 Tat |
| 000B71 (2008) |
Kenrad E. Nelson ; Hua Shan [États-Unis] | Reply |
| 000B79 (2008) |
H. Syed Iqbal [Inde] ; P. Balakrishnan [Inde] ; K. G. Murugavel [Inde] ; Solomon Suniti [Inde] | Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2 |
| 000B92 (2008) |
Jean-Pierre Allain [Royaume-Uni] ; Shirley Owusu-Ofori [Ghana] | Hepatitis C virus antibody confirmation in resource‐poor settings |
| 000C08 (2008) |
Claude Tayou Tagny [France] ; Dora Mbanya [France] ; Jean-Baptiste Tapko [France] ; Jean-Jacques Lefrère [France] | Blood safety in Sub‐Saharan Africa: a multi‐factorial problem |
| 000C58 (2007) |
Magda Anastassova Dineva [Royaume-Uni] ; Lourdes Mahilum-Tapaypresent Address Diagnostics For The Real World Ltd. Sunnyvale Ca Usa. [Royaume-Uni] ; Helen Lee [Royaume-Uni] | Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings |
| 000C90 (2007) |
Wing Chia-Ming Chuang [Royaume-Uni] ; Francis Sarkodie [Ghana] ; Colin J. Brown [Royaume-Uni] ; Shirley Owusu-Ofori [Ghana] ; Juliette Brown [Royaume-Uni] ; Chengyao Li [Royaume-Uni] ; Cristina Navarrete [Royaume-Uni] ; Paul Klenerman [Royaume-Uni] ; Jean-Pierre Allain [Royaume-Uni] | Protective effect of HLA‐B57 on HCV genotype 2 infection in a West African population |
| 000E10 (2006) |
Ellen Collenberg [Allemagne] ; Thierry Ouedraogo [Burkina Faso] ; Jean Ganamé [Burkina Faso] ; Helmut Fickenscher [Allemagne] ; Gisela Kynast-Wolf [Allemagne] ; Heiko Becher [Allemagne] ; Bocar Kouyaté [Burkina Faso] ; Hans-Georg Kr Usslich [Allemagne] ; Lassana Sangaré [Burkina Faso] ; Denis M. Tebit [Allemagne] | Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis |
| 000E26 (2006) |
Frank A. J. Konings [États-Unis] ; Sherri T. Burda [États-Unis] ; Mateusz M. Urbanski [États-Unis] ; Ping Zhong [République populaire de Chine] ; Arthur Nadas [États-Unis] ; Phillipe N. Nyambi [États-Unis] | Human immunodeficiency virus type 1 (HIV‐1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G |
| 000E86 (2005) |
Shirley Owusu-Ofori [Royaume-Uni] ; Jillian Temple [Royaume-Uni] ; Francis Sarkodie [Royaume-Uni] ; Margaret Anokwa [Royaume-Uni] ; Daniel Candotti [Royaume-Uni] ; Jean-Pierre Allain [Royaume-Uni] | Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings |
| 000F53 (2004) |
H. H. Lee [Royaume-Uni] ; J. P. Allain [Royaume-Uni] | Improving blood safety in resource‐poor settings |
| 000F56 (2004) |
François Rouet [Côte d'Ivoire] ; Marie-Laure Chaix [France] ; André Inwoley [Côte d'Ivoire] ; Philippe Msellati [Côte d'Ivoire] ; Ida Viho [Côte d'Ivoire] ; Patrice Combe [Côte d'Ivoire] ; Valériane Leroy [France] ; François Dabis [France] ; Christine Rouzioux [France] | HBV and HCV prevalence and viraemia in HIV‐positive and HIV‐negative pregnant women in Abidjan, Côte d'Ivoire: The ANRS 1236 study |
| 000F68 (2004) |
Jean-Pierre Allain [Royaume-Uni] ; Shirley Owusu-Ofori [Ghana] ; Imelda Bates [Royaume-Uni] | Blood Transfusion in Sub‐Saharan Africa |
| 001006 (2003) |
D. N. Mbanya [Cameroun] ; D. Takam ; P. M. Ndumbe [Cameroun] | Serological findings amongst first‐time blood donors in Yaoundé, Cameroon: is safe donation a reality or a myth? |
| 001105 (2001) |
F. Sarkodie [Ghana] ; M. Adarkwa [Ghana] ; Y. Adu-Sarkodie [Ghana] ; D. Candotti [Royaume-Uni] ; J. W. Acheampong [Ghana] ; J. P. Allain [Royaume-Uni] | Screening for viral markers in volunteer and replacement blood donors in West Africa |
| 001121 (2001) |
N. A. Smith [Royaume-Uni] ; T. Shaw [Royaume-Uni] ; N. Berry [Royaume-Uni] ; C. Vella [Royaume-Uni] ; L. Okorafor [Royaume-Uni] ; D. Taylor [Royaume-Uni] ; J. Ainsworth [Royaume-Uni] ; A. Choudhury [Royaume-Uni] ; R. S. Daniels [Royaume-Uni] ; S. El-Gadi [Royaume-Uni] ; A. Fakoya [Royaume-Uni] ; G. Moyle [Royaume-Uni] ; J. Oxford [Royaume-Uni] ; R. Tedder [Royaume-Uni] ; S. O'Shea [Royaume-Uni] ; A. De Ruiter [Royaume-Uni] ; J. Breuer [Royaume-Uni] | Antiretroviral Therapy for HIV-2 Infected Patients |
| 001160 (2000) |
Vincent Soriano [Espagne] ; Perpétua Gomes [Portugal] ; Walid Heneine [Géorgie (pays)] ; Africa Holguín [Espagne] ; Manuela Doruana [Portugal] ; Rute Antunes [Portugal] ; Kamal Mansinho [Portugal] ; William M. Switzer [Géorgie (pays)] ; Carlos Araujo [Portugal] ; Vedapuri Shanmugam [Géorgie (pays)] ; Helena Lourenço [Portugal] ; Juan González-Lahoz [Espagne] ; Francisco Antunes [Portugal] | Human immunodeficiency virus type 2 (HIV‐2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load |
| 001163 (2000) |
Aida Esteves [Portugal] ; Ricardo Parreira [Portugal] ; João Piedade [Portugal] ; Teresa Venenno [Portugal] ; Wanda F. Canas-Ferreira [Portugal] | Genetic characterization of HIV type 1 and type 2 from Bissau, Guinea-Bissau (West Africa) |
| 001169 (2000) |
Daniel Candotti [Royaume-Uni] ; Yaw Adu-Sarkodie [Ghana] ; Fiona Davies [Royaume-Uni] ; Eva Baldrich-Rubio [Royaume-Uni] ; Kathleen Stirrups [Royaume-Uni] ; Helen Lee [Royaume-Uni] ; Jean-Pierre Allain [Royaume-Uni] | AIDS in an HIV‐seronegative Ghanaian woman with intersubtype A/G recombinant HIV‐1 infection |
| 001195 (1999) |
Yoshitaka Isaka ; Akihiko Sato ; Shigeru Miki ; Shinobu Kawauchi ; Hitoshi Sakaida ; Toshiyuki Hori ; Takashi Uchiyama ; Akio Adachi ; Masanori Hayami ; Tamio Fujiwara ; Osamu Yoshie [Japon] | Small Amino Acid Changes in the V3 Loop of Human Immunodeficiency Virus Type 2 Determines the Coreceptor Usage for CXCR4 and CCR5 |
| 001200 (1999) |
J. Van Binsbergen [Pays-Bas] ; A. Siebelink [Pays-Bas] ; A. Jacobs [Pays-Bas] ; W. Keur [Pays-Bas] ; F. Bruynis [Pays-Bas] ; M. Van De Graaf [Pays-Bas] ; J. Van Der Heijden [Pays-Bas] ; D. Kambel [Pays-Bas] ; J. Toonen [Pays-Bas] | Improved performance of seroconversion with a 4th generation HIV Antigen/Antibody assay |
| 001202 (1999) |
Choo Beng Chew [Australie] ; Belinda L. Herring [Australie] ; Frank Zheng [Australie] ; Christine Browne [Australie] ; Nitin K. Saksena [Australie] ; Anthony L. Cunningham [Australie] ; Dominic E. Dwyer [Australie] | Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes |
| 001233 (1998) |
Robert K. Hickman [États-Unis] ; Ana Vallari [États-Unis] ; Alan Golden [États-Unis] ; Jennifer Lund [États-Unis] ; John Hackett Jr [États-Unis] ; Cathy Brennan [États-Unis] ; Sushil Devare [États-Unis] | Detection and differentiation of HIV-1 group O sera from HIV-1 group M and HIV-2 using recombinant antigens and peptides |
| 001239 (1998) |
J. Van Binsbergen [Pays-Bas] ; W. Keur [Pays-Bas] ; A. Siebelink [Pays-Bas] ; M. Van De Graaf [Pays-Bas] ; A. Jacobs [Pays-Bas] ; D. De Rijk [Pays-Bas] ; L. Nijholt [Pays-Bas] ; J. Toonen [Pays-Bas] ; L. G. Gürtler [Allemagne] | Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II |
| 001244 (1998) |
Yaw Adu-Sarkodie [Ghana] ; Affoué Sangaré ; Oscar A. D Lmeida [Togo] ; Georgette D. Kanmogne [Royaume-Uni] | Distribution of CD4+ T-lymphocytes levels in patients with clinical symptoms of AIDS in three West African countries |
| 001263 (1997) |
J. Van Binsbergen [Pays-Bas] ; W. Keur [Pays-Bas] ; M. V. D. Graaf [Pays-Bas] ; A. Siebelink [Pays-Bas] ; A. Jacobs [Pays-Bas] ; D. De Rijk [Pays-Bas] ; J. Toonen [Pays-Bas] ; L. Zekeng [Allemagne] ; E. Afane Ze [Allemagne] ; L. G Gürtler [Allemagne] | Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples |
| 001279 (1997) |
E. C. J. Consten ; J. T. M. Van Der Meer ; F. De Wolf ; H. A. Heij ; P. C. Henny ; J. J. B. Van Lanschot | Risk of iatrogenic human immunodeficiency virus infection through transfusion of blood tested by inappropriately stored or expired rapid antibody assays in a Zambian hospital |
| 001291 (1997) |
Y. A. Adu-Sarkodie [Ghana] | HIV antibody testing in a teaching hospital : Policy versus practice |
| 001315 (1996) |
T. Miura [Japon] ; R. Shibata [Japon] ; A. Adachi [Japon] ; T. Kuwata [Japon] ; J. Chen [Japon] ; M. Jin [Japon] ; E. Ido [Japon] ; M. Hayami [Japon] | Genetic complementation between replication-defective mutants of HIV-1 and SIVagm |
| 001352 (1995) |
Anne-Mieke Vandamme [Belgique] ; Sonia Van Dooren [Belgique] ; Wessel Kok [Pays-Bas] ; Patrick Goubau [Belgique] ; Katrien Fransen [Belgique] ; Tim Kievits [Pays-Bas] ; Jean-Claude Schmit [Belgique] ; Erik De Clercq [Belgique] ; Jan Desmyter [Belgique] | Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR |
| 001357 (1995) |
Akiko Tanabe-Tochikura [Japon] ; Maria Theresa Ang Singh [Japon] ; Hideaki Tsuchie [Japon] ; Jing Zhang [Japon] ; Fem Julia E. Paladin [Philippines] ; Takashi Kurimura [Japon] | A newly developed immunofluorescence assay for simultaneous detection of antibodies to human immunodeficiency virus type 1 and type 2 |
| 001372 (1995) |
N. Simonney [France] ; J. M. Molina [France] ; M. Molimard [France] ; E. Oksenhendler [France] ; C. Perronne [France] ; P. H. Lagrange [France] | Analysis of the immunological humoral response to Mycobacterium tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients |
| 001426 (1993) |
Sigrid Nick [Allemagne] ; Carlos A. Diniz [Allemagne] ; Gottfried Born [Allemagne] ; Marlies Sauter [Allemagne] ; Hans W. Pees [Allemagne] ; Nikolaus Müller-Lantzsch [Allemagne] ; Gerhard Jahn [Allemagne] | Molecular and biological characteristics of a novel HIV-2 isolate, HIV-2HOM |
| 001430 (1993) |
Yoshio Inouye [Japon] ; Yoshiki Tokutake [Japon] ; Tetsuya Yoshida ; Yoshiko Seto ; Haruhisa Hujita ; Katsuaki Dan ; Akihiro Yamamoto [Japon] ; Shigeki Nishiya [Japon] ; Toshihiro Yamase [Japon] ; Shoshiro Nakamura [Japon] | In vitro antiviral activity of polyoxomolybdates. Mechanism of inhibitory effect of PM-104 (NH4)12H2(Eu4(MoO4(H2O)16(Mo7O24)4) · 13H2O on human immunodeficiency virus type 1 |
| 001445 (1993) |
Terence E. Goubau [Belgique] ; J. Desmyter [Belgique] ; P. Swanson [États-Unis] ; M. Reynders [Belgique] ; J. Shih [États-Unis] ; I. Surmont [Belgique] ; K. Kazadi [Zaïre] ; H. Lee [États-Unis] | Detection of HTLV‐I and HTLV‐II infection in Africans using type‐specific envelope peptides |
| 001453 (1992) |
M. Odeh [Israël] ; A. Oliven [Israël] | Urticaria and angioedema induced by low-molecular-weight heparin |
| 001468 (1992) |
Wendy Grant [États-Unis] ; Frank J. Bia [États-Unis] ; Thomas M. Chacko [États-Unis] ; Michel Jean-Baptiste ; Brigitte P. Griffith [États-Unis] | Comparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti |
| 001475 (1992) |
T. S. Van Der Werf [Ghana, Pays-Bas] ; P. K. Das [Pays-Bas] ; D. Van Soolingen [Pays-Bas] ; S. Yong [Pays-Bas] ; T. W. Van Der Mark [Pays-Bas] ; R. Van Den Akker [Pays-Bas] | Sero-diagnosis of tuberculosis with A60 antigen enzyme-linked immunosorbent assay: failure in HIV-infected individuals in Ghana |
| 001479 (1992) |
H. Sakai [Japon] ; J. I. Sakuragi [Japon] ; S. Sakuragi [Japon] ; R. Shibata [Japon] ; M. Hayami [Japon] ; A. Ishimoto [Japon] ; A. Adachi [Japon] | Genetic characterization of simian immunodeficiency virus isolated from an African mandrill |
| 001496 (1991) |
H. H. Lee [États-Unis] ; P. Swanson [États-Unis] ; J. D. Rosenblatt [États-Unis] ; I. S. Y. Chen [États-Unis] ; W. C. Sherwood [Afrique du Sud] ; D. E. Smith [États-Unis] ; G. E. Tegtmeier [Royaume-Uni] ; L. P. Fernando [Royaume-Uni] ; C. T. Fang [États-Unis] ; M. Osame [Japon] ; S. H. Kleinman [États-Unis] | Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors |
| 001499 (1991) |
Nana K. Ayisi [Ghana] ; Sagar V. Gupta [Canada] ; Lou F. Qualtiere [Canada] | Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds |
